-
1دورية
المصدر: Pharmaceutical Patent Analyst; November 2018, Vol. 7 Issue: 6 p249-257, 9p
-
2
المؤلفون: Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Clive P. Page
المساهمون: Cazzola, Mario, Page, Clive, Calzetta, Luigino, Matera, Maria Gabriella
المصدر: Pharmaceutical patent analyst. 7(6)
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, medicine.drug_class, Phosphodiesterase 3, Anti-Inflammatory Agents, Pulmonary disease, Pyrimidinones, Phosphodiesterase 3 Inhibitors, Gastroenterology, Cystic fibrosis, mixed phosphodiesterase (PDE)3/4 inhibitor, Patents as Topic, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Bronchodilator, Internal medicine, Administration, Inhalation, medicine, COPD, Animals, Humans, Bifunctional, cystic fibrosi, Asthma, business.industry, Medicine (all), General Medicine, medicine.disease, ensifentrine, Isoquinolines, PDE isoenzyme, respiratory tract diseases, Bronchodilator Agents, 030104 developmental biology, 030228 respiratory system, chemistry, Phosphodiesterase 4 Inhibitors, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad91ccb7545abc26a9189bda374478cTest
https://pubmed.ncbi.nlm.nih.gov/30657422Test